Clearbridge NanoMedics is a National University of Singapore (NUS) spin-off company focused on developing, manufacturing and commercialising nanofibres.
With proprietary technology developed and patented by a team of NUS engineers, we specialise in tailoring and producing electrospun nanofibres for cosmetics, advanced wound care and time-release drug delivery. We look forward to shaping the future of advanced material technology, one strand at a time.
Mr Johnson Chen
Mr Chen is the Managing Partner for Clearbridge Partners, an Asian based venture capital firm. He is also the Managing Partner for Clearbridge Accelerator, a technology incubator recently set-up in Singapore. Clearbridge Accelerator was awarded co-funding support by the Singapore's National Research Foundation (NRF) under their Technology Incubator Scheme (TIS) to help nurture and develop high-technology start-ups.
Prior to founding Clearbridge, Mr Chen worked at Pacific Century CyberWorks Limited, the incumbent and leading telecommunications company in Hong Kong. Mr Chen is a member of the pioneering team at PCCW and was the President of CyberWorks Ventures, the Venture Capital and direct investment arm of PCCW. Mr Chen was also the youngest member of PCCW's Mergers & Acquisitions executive committee, and was responsible for much of PCCW's strategic expansion and many of its successful acquisitions and investments.
Mr Chen has more than 12 years of entrepreneurship experience with start-ups, being the co-founder of 2 start-up companies, and where both companies were successfully exited. Mr Chen has also given talks on entrepreneurship in Hong Kong and the United States, including the Sloan School of Management at MIT. Mr Chen is an active angel investor and is a member of the Hong Kong Science and Technology Park (HKSTP) incubator selection panel.
Mr Chen is also the recipient of the prestigious Sword of Honour, awarded by the President of Singapore, for graduating top in his officer cadet course during his national service with the Singapore Armed Forces.
Mr Chen holds a B.A., M.A. and M.Eng from the University of Cambridge, (U.K.).
Professor Lim Chwee Teck
Professor Lim Chwee Teck currently holds joint appointments at both the Departments of Bioengineering and Mechanical Engineering at the National University of Singapore (NUS). He is also a Principal Investigator at the Mechanobiology Institute as well as a Fellow of the Singapore-MIT Alliance. Professor Lim heads the Nano Biomechanics Lab which conducts basic and applied research in cell and molecular biomechanics and mechanobiology of human diseases as well as development of mechanics based label-free micro/nano biomedical devices.
Prof Lim has authored more than 165 journal papers (including 24 invited/review articles and 8 ISI highly cited papers), 16 book chapters and delivered more than 140 plenary/keynote/invited talks. He is currently on the editorial boards of 8 international journals. Prof Lim has recently been elected as a Council Member of the World Council for Biomechanics. He has co-founded 3 start-up companies that exploit inventions that he has developed in his lab.
Prof Lim has won several research awards and honors including the IES Prestigious Engineering Achievement Award, highly cited author award, Best Paper awards and Best Poster awards in international conferences. His research was cited by the MIT Technology Review magazine as one of the top ten emerging technologies of 2006 that will "have a significant impact on business, medicine or culture".
Mr Chong Chee Wah
Mr Chong previously worked as a Communications Security Program Manager at the DSO National Laboratories. He won the prestigious KINETIC Award in DSO for his outstanding technical contributions to various initiatives in the defence sector. He oversaw various cryptographic and communication systems as well as direct research & development investments in excess of S$5 million annually. He was also the key technical decision maker on various national level projects.
Prior to working at DSO, Mr Chong was with the Directorate of Research & Development (under the Defence Science & Technology Agency) as a Country Manager, where he was responsible for the long term strategic R&D plans for the Ministry of Defence. Mr Chong was also the Assistant Director of Finance Policy at the Ministry of Health (MOH) where his responsibilities included policy matters on Singapore's key medical financial schemes.
Mr Chong is the recipient of the Public Service Commission's Local Merit Scholarship and has a B.Eng and M.Eng (Electrical Engineering) from the National University of Singapore.
Dr Henry Leung
Dr Leung is a seasoned research scientist executive with deep pharmacology experience.
Prior to joining Clearbridge NanoMedics, Dr Leung served five years in R&D and lecturing at Nanyang Polytechnic (NYP), Singapore. At NYP, Dr Leung was appointed as senior lecturer and held the principle investigator role for number of high impact projects for the School of Chemical and Life Science, including NRF-TRD model project, SPRING-IDS model project with local TCM (Traditional Chinese Medicine) company- Eu Yan Sang, and other local SMEs-Polytechnic projects. Dr Leung was also named inventor for five international patents and one patent commercialisation with Intellecutual Venturers, US. Prior to NYP, Dr Leung had served as research scientist at former Mitsubishi Chemical Co Ltd, Japan and The Chinese University of Hong Kong.
Dr Leung holds a B.Sc. in Pharmacology and Toxicology from King’s College, London, a M.Sc. in Toxicology from University of Surry, UK and Ph.D. in Pharmacology from The Chinese University of Hong Kong.